Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02829632 · ClinicalTrials.gov registry record · NA
Feasibility Study of Receiving Feedback Messages Based on Self-monitored Dietary Intake
A NA study of Obesity and Overweight, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT02829632: Completed NA study of Obesity and Overweight, sponsored by University of Pittsburgh.
NCT02829632 is a NA study of Obesity and Overweight that has completed, run by University of Pittsburgh. The registered enrollment target is 39 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02829632, a NA study of Obesity and Overweight, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
Brief Summary: This randomized clinical pilot will test the feasibility of having individuals self-monitor for 12 weeks and based on what the participants record be given feedback messages. The investigator will use this information to refine the questions and data collection procedures for the larger study. Participants will be randomized into 3 groups * self-monitoring only * self-monitoring w/ feedback messages * self-monitoring w/feedback messages and group sessions Feedback messages will be delivered up to 4 times per day using a different schedule. The group sessions will be held in the 2nd, 4th and 8th week of the 12-week study. All participants will be asked to complete questionnaires and 2 assessment visits at baseline and 12 weeks.
Primary Outcome
Changes in weight: measured as Percent change in weight from baseline to 12 weeks
Conditions Studied
Interventions
- BEHAVIORAL Self-monitoring
- BEHAVIORAL Group Sessions
- BEHAVIORAL Feedback
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2015-03 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT02829632 record still lists
NCT02829632 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Self-monitoring is the first listed.
NCT02829632 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02829632 about?
NCT02829632 is a clinical study titled "Feasibility Study of Receiving Feedback Messages Based on Self-monitored Dietary Intake". Brief Summary: This randomized clinical pilot will test the feasibility of having individuals self-monitor for 12 weeks and based on what the participants record be given feedback messages. The investigator will use this information to refine the questions and data collection procedures for the larg...
What is the current status of trial NCT02829632?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2015-03. Estimated completion is 2015-06.
What conditions does trial NCT02829632 study?
This clinical trial studies the following conditions: Obesity, Overweight.
What interventions are being tested in trial NCT02829632?
The interventions under investigation include: Self-monitoring (BEHAVIORAL), Group Sessions (BEHAVIORAL), Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT02829632?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02829632 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02829632's enrollment target sits among peer trials
39 806th of 1053 higher than 244 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia